Enrolment for the US-based trial is scheduled to start in mid-2026, with initial results expected in the fourth quarter.
Topline data from the trial are expected in the first quarter of 2027.
The trial assessed the graphene-based cortical interface during neurosurgical procedures for brain tumour resection.
Learn more TG Therapeutics has completed enrolment in its Phase III trial investigating subcutaneous Briumvi ...
Employers are already starting to face automatic re-enrolment for their employees who are eligible jobholders not already in qualifying schemes; here are some of the pitfalls to look out for. Know the ...
If you would like clarification for the reason(s) you are temporary enrolled, please login to MySIS and visit the 'My Enrolment' tab where you can view the reason(s) you have been granted temporary ...